TBB_WHITE LOGO

The Blue Box

Company  |
Spain, Barcelona

Primary tabs

About your organization / profile

1 in 8 women will have breast cancer (BC) at least once, with it being the most commonly diagnosed cancer among women worldwide. Shockingly, although BC is one of the most treatable cancers, it is the most deadly cancer in women. The main reason for this is not a lack of treatment options but rather a lack of accessibility to an early-stage diagnosis. Indeed, mammography does not provide clear visualization of small tumors in young women, who have dense breast tissue. Hence, most healthcare systems only invite women aged 50-69 to mammogram-based screenings, but 27% of BCs will happen to young women outside the screening age.

This is why we have built The Blue Box. Our technology is more sensitive (88.33% vs 56.10%) and accurate (83.32% vs 70.40%) than mammography for young women (<50). I.e., an additional 30% of women with BC could be diagnosed with The Blue Box. We will provide women aged 20-49 with a reliable, accessible radiation-free, pain-free, low-cost and easy-to-operate device to detect breast cancer in urine, so that they can be breast cancer diagnosed in time.

News

Network (0)

There are no organizations in the network.

Recent activities

Avatar

The Blue Box has been awarded the InvestEU Portal  label.

Avatar

GIRÓ JUDIT (Member, The Blue Box) has published an article on The Blue Box's page.

Avatar

GIRÓ JUDIT (Member, The Blue Box) has published an article on The Blue Box's page.

Avatar

The dataroom has been updated.

Avatar

GIRÓ JUDIT has joined The Blue Box